Every November, Lung Cancer Awareness Month asks us to look harder at the world’s deadliest cancer. Why does awareness still matter? The numbers answer that.…
A fever that won’t break. Cultures that stay negative. A patient on antibiotics nobody can name a target for. What if one test could check…
The Clinical Challenge Arjun is 28. He writes code for a living, plays cricket on weekends, and for almost a year, every morning has started…
It’s Breast Cancer Awareness Month, and we’re looking beyond awareness alone, toward the molecular insights that can support earlier risk assessment, better disease characterization, and…
If you had to guess how many people die from sepsis each year, what would you say? A few hundred thousand? A million? The global…
One gene panel. Three diagnoses sorted out. No guessing. Memories fail. There’s a tremor that refuses to go away. A word that cannot be recalled.…
Blood cancer is more than a diagnosis. But how much do we really know about what lies beneath it? Recognizing the signs and seeking timely…
A tumour sample may look like a small piece of tissue, but from a genomic point of view, it contains a large amount of information.…
Molecular diagnostic instrumentation has come a long way, from first-generation thermal cyclers to today’s sleek, software-driven platforms. Every so often, a system comes along that…
In the rapidly evolving landscape of clinical genomics, next-generation sequencing (NGS) has achieved remarkable milestones on the wet-lab side. High-precision, target-enriched panels—such as the Genes2Me…